NACBO 2021 Connected
Date: 9/07/2021-11/07/2021 (AEST)
Venue: Live Webinar - Online, QLD, 4217
Provider: ACBO
Contact: Maria Gorbunova, [E] admin@acbo.org.au, [P] 0396143400
Learning Objectives
- 3. 1. Review current opinion in vision science, education and psychology research about role of vision in learning
2. Provide an evidence-based rationale for including an evaluation of visual information processing in primary aged children
3. Identify when VIP testing is indicated and know what VIP tests to administer based on clinical history and work up.
- 4.1. Describe the benefits and disadvantages of using in-office and out-of-office vision therapy software systems in general.
2. Evaluate the different features of the available in-office vision therapy systems.
3. Judge the activity lists and presentation systems of software for delivering home vision therapy as part of office vision therapy.
- 5.1. Demonstrate an awareness of new research in testing visual cognition with a novel dot pattern test
- 6.1 Characterise the binocular vision system functions which are commonly assessed in a binocular vision workup.
2. Recognise the benefits and limitations of available binocular vision instruments, including stereo and phoria tests, Maddox rod, Maddox and Risley prism combination, Medmont Zone of Single Vision and computerised Hess Screen tests.
3. Review the application of specialized binocular vision assessment tools in complex binocular vision dysfunctions.
- 7.1Recall history of non-occlusive treatment of amblyopia, the development of Monocular Function in a Binocular Field (MFBF) theory & practice 2.Characterise the scope of visual performance problems in amblyopia substantiated by research 3.Know the research evidence which supports the non-occlusive paradigm for treatment of anisometropic amblyopia 4.Prescribe the program’s sequential treatment components, as indicated, of neuro-balancing prescription & dispensing, MFBF & optometric phototherapy.
- 8.1 Describe the components of amblyopia visual assessment, including visual acuity, stereo, Worth 4 dot, and near retinoscopy reflex brightness.
2.Characterise the integration of full spectrum of amblyopia therapy tools, ranging from lens management to optometric syntonic phototherapy for different case presentations. 3.Employ adjustment of the prescriptions for both the amblyopic and non-amblyopic to optimise binocular function
- 11.1. understand the differences between a hill of vision on the HFA vs. a mesa of vision as tested by the MRF as well as seeing how close these two different systems are to each other.
2. understand how much more robust visual field testing is in terms of fault tolerance to the lenses used during the testing as well as ambient lighting.
3. understand how automated OKN testing can and does measure visual acuity to a highly accurate degree in between 35 and 45 seconds per condition tested.
- 12. 1. Question patients re visual distortions in mental health issues
2.Test for visual distortions in mental health sufferers
3. Prescribe lenses.tinted lenses, and vision therapy for visual distortions IN Mental health sufferers
- 13.1. Gain an understanding of the recent research findings on myopia development during the COVID 19 pandemic
2. Learn about new myopia treatment options
3. Learn about the management options on pre-myopia and how to best incorporate binocular vision aspects in the management plan
- 1.1.Describe learning related vision problems commonly seen by behavioural optometrists
2.Apply theories of movement science, schema theory, neuroplasticity, and motor learning to visually - directed action during vision therapy (VT) and the classroom.
3.Review current literature on neurologic pathways for eye movement control for application to vision therapy.
- 1.4.Differentiate patient behaviour and clinical findings to customize care
5.Differentiate the main presenting types of patients (hyperkinesis or disengagement) with persistent poor attention to visual detail.
6.Discuss how excess verbal feedback during care overwhelms the patient struggling to integrate vision and movement.
- 2.1.Integrate theory and practice to engage vision within the first VT sessions using Near/far fixation as a clinical example.
2.Employ theory and practice to engage vision early in vision therapy using coding for language as a clinical example.
- 2.3 Implement practical strategies for vision therapy to address learning related vision issues which translates more rapidly into function.
4. Reproduce virtual practice of specific communication skills such as verbal and tactile cues to engage subconscious motor systems and avoid overwhelm.
- 9.1. Describe the relationship of nutrition, particularly the gut microbiome, to brain function
2.Explain the connection of nutrition to auto-immunity and inflammation
3.Implement optometric history and assessment of patients to establish possible connections between patient signs and symptoms, with nutrition and the gut biome.
- 10. 1.Describe the possible visual symptoms and effects of patients presenting with complaints of dizziness.
2.Perform a regime of testing procedures to discern if specific visual conditions are involved with the dizziness issues.
3.Prescribe appropriate optometric clinical treatment options to manage visual symptoms associated with dizziness.
Max CPD hours awarded: 13.75
Session Information
Name |
---|
Learning With Vision 1 |
Clinical? |
---|
Yes |
Interactive? |
---|
No |
Therapeutic? |
---|
No |
Duration of CPD Session/Module |
---|
2 |
Duration of CPD Session/Module inclusive of Assessment Component |
---|
2 |
Name |
---|
Learning With Vision 2 |
Clinical? |
---|
Yes |
Interactive? |
---|
No |
Therapeutic? |
---|
No |
Duration of CPD Session/Module |
---|
1.5 |
Duration of CPD Session/Module inclusive of Assessment Component |
---|
1.5 |
Name |
---|
Visual Information Processing Testing in Optometry – When Why What How? |
Clinical? |
---|
Yes |
Interactive? |
---|
No |
Therapeutic? |
---|
No |
Duration of CPD Session/Module |
---|
1.5 |
Duration of CPD Session/Module inclusive of Assessment Component |
---|
1.5 |
Name |
---|
Vision therapy systems and programs |
Clinical? |
---|
Yes |
Interactive? |
---|
No |
Therapeutic? |
---|
No |
Duration of CPD Session/Module |
---|
0.5 |
Duration of CPD Session/Module inclusive of Assessment Component |
---|
0.5 |
Name |
---|
The Dot pattern Visual Cognition task for assessment of visual sequencing and visualisation aptitude in elementary school children |
Clinical? |
---|
Yes |
Interactive? |
---|
No |
Therapeutic? |
---|
No |
Duration of CPD Session/Module |
---|
0.5 |
Duration of CPD Session/Module inclusive of Assessment Component |
---|
0.5 |
Name |
---|
Binocular Vision assessment and management: equipment and software |
Clinical? |
---|
Yes |
Interactive? |
---|
No |
Therapeutic? |
---|
No |
Duration of CPD Session/Module |
---|
0.5 |
Duration of CPD Session/Module inclusive of Assessment Component |
---|
0.5 |
Name |
---|
A new paradigm of amblyopia treatment: the Sanet-Vergara Neuro-Functional Amblyopia Treatment Protocol |
Clinical? |
---|
Yes |
Interactive? |
---|
No |
Therapeutic? |
---|
No |
Duration of CPD Session/Module |
---|
1.25 |
Duration of CPD Session/Module inclusive of Assessment Component |
---|
1.25 |
Name |
---|
A new paradigm of amblyopia treatment: the Sanet-Vergara Neuro-Functional Amblyopia Treatment Protocol |
Clinical? |
---|
Yes |
Interactive? |
---|
No |
Therapeutic? |
---|
No |
Duration of CPD Session/Module |
---|
1.5 |
Duration of CPD Session/Module inclusive of Assessment Component |
---|
1.5 |
Name |
---|
Nutrition, vision, the gut microbiome and the brain |
Clinical? |
---|
Yes |
Interactive? |
---|
No |
Therapeutic? |
---|
No |
Duration of CPD Session/Module |
---|
1 |
Duration of CPD Session/Module inclusive of Assessment Component |
---|
1 |
Name |
---|
Optometric assessment and management of the patient with dizziness or vertigo |
Clinical? |
---|
Yes |
Interactive? |
---|
No |
Therapeutic? |
---|
No |
Duration of CPD Session/Module |
---|
1 |
Duration of CPD Session/Module inclusive of Assessment Component |
---|
1 |
Name |
---|
Research Updates From SCO - MRF Tablet & Home and Automated VA Using OKN |
Clinical? |
---|
Yes |
Interactive? |
---|
No |
Therapeutic? |
---|
No |
Duration of CPD Session/Module |
---|
1 |
Duration of CPD Session/Module inclusive of Assessment Component |
---|
1 |
Name |
---|
Colorimetry in management of visual symptoms resulting from treatment of schizophrenia |
Clinical? |
---|
Yes |
Interactive? |
---|
No |
Therapeutic? |
---|
No |
Duration of CPD Session/Module |
---|
0.5 |
Duration of CPD Session/Module inclusive of Assessment Component |
---|
0.5 |
Name |
---|
Brien Holden Institute invited lecture: current management of myopia |
Clinical? |
---|
Yes |
Interactive? |
---|
No |
Therapeutic? |
---|
No |
Duration of CPD Session/Module |
---|
1 |
Duration of CPD Session/Module inclusive of Assessment Component |
---|
1 |
Name | Clinical? | Interactive? | Therapeutic? | CPD Hours |
---|
Learning With Vision 1 | Yes | No | No | 2 | 2 |
Learning With Vision 2 | Yes | No | No | 1.5 | 1.5 |
Visual Information Processing Testing in Optometry – When Why What How? | Yes | No | No | 1.5 | 1.5 |
Vision therapy systems and programs | Yes | No | No | 0.5 | 0.5 |
The Dot pattern Visual Cognition task for assessment of visual sequencing and visualisation aptitude in elementary school children | Yes | No | No | 0.5 | 0.5 |
Binocular Vision assessment and management: equipment and software | Yes | No | No | 0.5 | 0.5 |
A new paradigm of amblyopia treatment: the Sanet-Vergara Neuro-Functional Amblyopia Treatment Protocol | Yes | No | No | 1.25 | 1.25 |
A new paradigm of amblyopia treatment: the Sanet-Vergara Neuro-Functional Amblyopia Treatment Protocol | Yes | No | No | 1.5 | 1.5 |
Nutrition, vision, the gut microbiome and the brain | Yes | No | No | 1 | 1 |
Optometric assessment and management of the patient with dizziness or vertigo | Yes | No | No | 1 | 1 |
Research Updates From SCO - MRF Tablet & Home and Automated VA Using OKN | Yes | No | No | 1 | 1 |
Colorimetry in management of visual symptoms resulting from treatment of schizophrenia | Yes | No | No | 0.5 | 0.5 |
Brien Holden Institute invited lecture: current management of myopia | Yes | No | No | 1 | 1 |